NCT01362296 - An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

134

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2013

Conditions

Lung Cancer, Non-Small Cell

Interventions

DRUG

GSK1120212

Oral once daily

DRUG

docetaxel

IV once every 3 weeks

Trial Locations (60)

1529

GSK Investigational Site, Budapest

2045

GSK Investigational Site, Törökbálint

8000

GSK Investigational Site, Székesfehérvár

13915

GSK Investigational Site, Marseille

16132

GSK Investigational Site, Genoa

18547

GSK Investigational Site, Neo Faliro

19104

GSK Investigational Site, Philadelphia

19141

GSK Investigational Site, Philadelphia

20133

GSK Investigational Site, Milan

20141

GSK Investigational Site, Milan

22031

GSK Investigational Site, Fairfax

27710

GSK Investigational Site, Durham

28034

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28050

GSK Investigational Site, Madrid

28222

GSK Investigational Site, Majadahonda (Madrid)

30607

GSK Investigational Site, Athens

31008

GSK Investigational Site, Pamplona

31059

GSK Investigational Site, Toulouse

32224

GSK Investigational Site, Jacksonville

38120

GSK Investigational Site, Memphis

43210

GSK Investigational Site, Columbus

46202

GSK Investigational Site, Indianapolis

48201

GSK Investigational Site, Detroit

55404

GSK Investigational Site, Minneapolis

55905

GSK Investigational Site, Rochester

57010

GSK Investigational Site, Thessaloniki

63110

GSK Investigational Site, St Louis

67091

GSK Investigational Site, Strasbourg

71110

GSK Investigational Site, Heraklion, Crete

75230

GSK Investigational Site, Paris

75908

GSK Investigational Site, Paris

75970

GSK Investigational Site, Paris

77030

GSK Investigational Site, Houston

78731

GSK Investigational Site, Austin

80045

GSK Investigational Site, Aurora

83814

GSK Investigational Site, Coeur d'Alene

85259

GSK Investigational Site, Scottsdale

92868

GSK Investigational Site, Orange

94805

GSK Investigational Site, Villejuif

97239

GSK Investigational Site, Portland

98684

GSK Investigational Site, Vancouver

21231-2410

GSK Investigational Site, Baltimore

02114

GSK Investigational Site, Boston

02215

GSK Investigational Site, Boston

03756

GSK Investigational Site, Lebanon

115 22

GSK Investigational Site, Athens

115 27

GSK Investigational Site, Athens

1066 CX

GSK Investigational Site, Amsterdam

1081 HV

GSK Investigational Site, Amsterdam

4818 CK

GSK Investigational Site, Breda

9713 GZ

GSK Investigational Site, Groningen

6229 HX

GSK Investigational Site, Maastricht

8011 JW

GSK Investigational Site, Zwolle

110-744

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

08916

GSK Investigational Site, Badalona

08035

GSK Investigational Site, Barcelona